Page 21 - Third Point Ventures News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Forter Doubles Revenue in Last 12 Months; Raises $300M for a $3B Valuation on May 25 2021 11:15 PM Driven by the Recent Imperatives of Rapid Digital Transformation, The Largest Retailers Around the Globe Are Now Relying on Forter’s Real-Time Frictionless Fraud & Abuse Prevention Platform to Fuel Growth NEW YORK--(BUSINESS WIRE)--Forter, the leader in e-commerce fraud prevention, today announced it has raised $300 million in Series F funding led by Tiger Global Management, with participation from Third Point Ventures and Adage Capital Management. Existing investors also participated includin...

Sysdig, Inc., a San Francisco, CA-based secure DevOps platform provider, raised $188m in Series F funding round at a valuation of $1.19 billion. This round, which brought total funding to $394m since inception, was led by Premji Invest & Associates and Third Point Ventures, with participation from Accel, Bain Capital Ventures, DFJ Growth, Glynn Capital, Goldman Sachs, Insight Partners, and Next47. In conjunction with the funding, Robert Schwartz from Third Point Ventures, Sandesh Patnam from Premji Invest & Associates, and Enrique Salem from Bain Capital Ventures, joined Susdig’s board of...

Funding follows accelerating growth and open source community momentum, and positions Sysdig to emerge as the leader in container and cloud security Sysdig, Inc., the secure DevOps leader, today

SHARE Container environment security startup Sysdig Inc. joined the unicorn club today after raising $188 million in a late-stage funding round. The Series F round, led by Third Point Ventures and Premji Invest with participation from Accel, Bain Capital Ventures, DFJ Growth, Goldman Sachs, Insight Partners and Next47, brings Sysdig’s value to $1.18 billion, the company said. Sysdig, which last raised $70 million in January 2020, sells tools for securing container environments that are used to host modern software applications that can run on any computing platform. Its main product is Sysd...

Search jobs RubrYc Therapeutics Announces a Research Collaboration and License Option Agreement With Zai Labs SAN CARLOS, Calif.--(BUSINESS WIRE)--RubrYc Therapeutics, Inc., a pre-clinical biotherapeutics company developing epitope selective therapies, today announced that it has entered into a research collaboration and license option agreement with Zai Labs, Inc. for the use of RubrYc’s Meso-scale Engineered Molecules (MEMs) platform, to identify monoclonal antibodies with enhanced biological function for an undisclosed oncology target. Under the terms of the agre...